Where is the right ventricle? Accurate diagnosis with cardiovascular multimodality imaging.
Ahmet GunerÇağdaş TopelAysel Türkvatan CanseverEzgi Gültekin GünerOmaç TüfekcioğluMehmet ErtürkGamze Babür GülerPublished in: Echocardiography (Mount Kisco, N.Y.) (2020)
Endomyocardial fibrosis (EMF) is a globally unattended disease with significant rates of morbidity and mortality. It has a higher prevalence in tropical and subtropical countries compared to the rest of the world. Endomyocardial fibrosis can affect the atrioventricular valves, along with all four chambers of the heart, but spares the myocardium. Patients currently undergo symptomatic treatment with diuretics and vasodilators to enhance quality of life, although medical therapy alone is associated with poor prognosis. Hence, patients with severe symptoms prefer surgical treatment. Modern multimodality imaging, however, can help these definitions to be made more accurately.
Keyphrases
- poor prognosis
- high resolution
- end stage renal disease
- long non coding rna
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- peritoneal dialysis
- risk factors
- climate change
- aortic valve
- physical activity
- pulmonary hypertension
- pulmonary artery
- patient reported outcomes
- coronary artery
- left ventricular
- mesenchymal stem cells
- fluorescence imaging
- aortic valve replacement
- bone marrow
- smoking cessation
- drug induced
- combination therapy
- aortic stenosis